- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 513/22 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or in which the condensed system contains four or more hetero rings
Patent holdings for IPC class C07D 513/22
Total number of patents in this class: 318
10-year publication summary
|
12
|
12
|
5
|
8
|
9
|
21
|
23
|
38
|
38
|
45
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Vertex Pharmaceuticals Incorporated | 1630 |
16 |
| Revolution Medicines, Inc. | 267 |
15 |
| Hoffmann-La Roche Inc. | 3546 |
12 |
| Merck Patent GmbH | 5752 |
12 |
| Gilead Sciences, Inc. | 2106 |
12 |
| F. Hoffmann-La Roche AG | 7937 |
9 |
| Janssen Pharmaceutica N.V. | 3358 |
8 |
| Hangzhou DAC Biotech Co., Ltd | 105 |
8 |
| Sumitomo Chemical Company, Limited | 9109 |
7 |
| Raynergy Tek Inc. | 111 |
6 |
| Nuvalent, Inc. | 77 |
6 |
| Genzyme Corporation | 1314 |
5 |
| Bristol-myers Squibb Company | 4826 |
4 |
| Massachusetts Institute of Technology | 10150 |
4 |
| University of Sharjah | 49 |
4 |
| Sionna Therapeutics, Inc. | 20 |
4 |
| Novartis AG | 10612 |
3 |
| Samsung Display Co., Ltd. | 36317 |
3 |
| Amgen Inc. | 4256 |
3 |
| FUJIFILM Corporation | 29839 |
3 |
| Other owners | 174 |